While it had already been approved as an adjunct therapy for partial-onset seizures, Aptiom has been tested as a monotherapy as well. The benefits of the single treatment option go beyond overall…
While it had already been approved as an adjunct therapy for partial-onset seizures, Aptiom has been tested as a monotherapy as well. The benefits of the single treatment option go beyond overall…
Comments